Coexistence of Interstitial Nephritis and the Cellular Variant of Focal Segmental Glomerulosclerosis Secondary to Anabolic Steroid Abuse.
Journal
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
ISSN: 1319-2442
Titre abrégé: Saudi J Kidney Dis Transpl
Pays: Saudi Arabia
ID NLM: 9436968
Informations de publication
Date de publication:
01 Nov 2022
01 Nov 2022
Historique:
medline:
30
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
ppublish
Résumé
Anabolic-androgenic steroids (AAS) have been widely used by young people to enhance performance and increase muscle mass. The use of AAS can affect the kidneys and lead to a myriad of presentations, ranging from mildly elevated serum creatinine and blood urea nitrogen to irreversible chronic kidney disease and focal segmental glomerulosclerosis (FSGS). To the best of our knowledge, the coexistence of interstitial nephritis and the cellular variant of FSGS [Immunoglobulin M (IgM)] secondary to AAS abuse has not been previously reported in the literature. Here, we report the case of a 40-year-old bodybuilder who developed simultaneous interstitial nephritis and the cellular variant of FSGS (IgM) after short-term use of AAS and other dietary supplements.
Identifiants
pubmed: 38018725
doi: 10.4103/1319-2442.390263
pii: 00936703-202233060-00012
doi:
Substances chimiques
Anabolic Androgenic Steroids
0
Testosterone Congeners
0
Immunoglobulin M
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
839-843Informations de copyright
Copyright © 2022 Copyright: © 2022 Saudi Journal of Kidney Diseases and Transplantation.
Références
Bird SR, Goebel C, Burke LM, Greaves RF. Doping in sport and exercise: Anabolic, ergogenic, health and clinical issues. Ann Clin Biochem 2016;53:196-221.
Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 2001;23:1355-90.
Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008;371:1872-82.
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: A metaanalysis and meta-regression analysis. Ann Epidemiol 2014;24:383-98.
Goldman A, Basaria S. Adverse health effects of androgen use. Mol Cell Endocrinol 2018;464:46-55.
Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: A systematic review. BMC Nephrol 2019;20:198.
Herlitz LC, Markowitz GS, Farris AB, et al. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol 2010;21:163-72.
El-Reshaid W, El-Reshaid K, Al-Bader S, Ramadan A, Madda JP. Complementary bodybuilding: A potential risk for permanent kidney disease. Saudi J Kidney Dis Transpl 2018;29:326-31.
Almukhtar SE, Abbas AA, Muhealdeen DN, Hughson MD. Acute kidney injury associated with androgenic steroids and nutritional supplements in bodybuilders(†). Clin Kidney J 2015;8:415-9.
Hartung R, Gerth J, Fuüfstück R, Gröne HJ, Stein G. End-stage renal disease in a bodybuilder: A multifactorial process or simply doping? Nephrol Dial Transplant 2001;16:163-5.
Ahmed AK, Aldabbagh Y. Does gymnasium harbor an endemic cause of end stage kidney disease? A case report & review of literature. Urol Nephrol Open Access J 2019;7:5557.
Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011;40:1271-96.
Gualano B, Roschel H, Lancha AH Jr, Brightbill CE, Rawson ES. In sickness and in health: The widespread application of creatine supplementation. Amino Acids 2012;43:519-29.
Buford TW, Kreider RB, Stout JR, et al. International society of sports nutrition position stand: Creatine supplementation and exercise. J Int Soc Sports Nutr 2007;4:6.
Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989;13:443-56.
Schwimmer JA, Markowitz GS, Valeri AM, Imbriano LJ, Alvis R, D'Agati VD. Secondary focal segmental glomerulosclerosis in nonobese patients with increased muscle mass. Clin Nephrol 2003;60:233-41.
National Research Council, Commission on Life Sciences, Food and Nutrition Board: Subcommittee on the Tenth Edition of the Recommended Dietary Allowance. Recommended Dietary Allowances. 10th ed. Washington, D.C.: National Academies Press; 1989.
Martin WF, Armstrong LE, Rodriguez NR. Dietary protein intake and renal function. Nutr Metab (Lond) 2005;2:25.
Fink HH, Burgoon LA, Mikesky AE. Practical Applications in Sports Nutrition. 2nd ed. Sweden; 2009.
Taner B, Aysim O, Abdulkadir U. The effects of the recommended dose of creatine monohydrate on kidney function. NDT Plus 2011;4:23-4.
Sandhu RS, Como JJ, Scalea TS, Betts JM. Renal failure and exercise-induced rhabdo-myolysis in patients taking performanceenhancing compounds. J Trauma 2002;53:761-3.
Ardalan M, Samadifar Z, Vahedi A. Creatine monohydrate supplement induced interstitial nephritis. J Nephropathol 2012;1:117-20.
Thorsteinsdottir B, Grande JP, Garovic VD. Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate. J Ren Nutr 2006;16:341-5.